Top Markets
Coin of the day
Innovation1 Biotech Inc. Innovation1 Biotech Inc.

Innovation1 Biotech Inc.

IVBT
Rang in aandelen #42121
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily... Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprietary prodrugs that are currently in preclinical development, each designed to tackle a unique set of medical conditions. Specifically, these include a psychedelic compound derived from mushrooms, aimed at treating post-traumatic stress disorder and depression; an innovative cannabinoid and tree bark-sourced psychedelic intended to combat addiction; and three additional cannabinoid prodrugs targeting refractory pediatric epilepsy, hypertrophic scarring, and inflammation of the eye. Established in 2014 and headquartered in New York, New York, the company was previously named Gridiron BioNutrients, Inc. before adopting its current moniker, Innovation1 Biotech Inc., in March 2022.
Aandeelprijs
$0.0002
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$4.49K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Innovation1 Biotech Inc. (IVBT)

Categorie

Koersgeschiedenis voor Innovation1 Biotech Inc. (IVBT)
Hoogste slotkoers: $0.00 op 2026-08-01

Laagste slotkoers: $0.88 op 2017-09-01
Koersgeschiedenis van Innovation1 Biotech Inc. van 2017 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.00%
2025 -80.00%
2024 -99.38%
2023 69.91%
2022 -96.64%
2021 24,327.45%
2020 19.32%
2019 -82.73%
2018 -95.26%
2017 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$1.08K -6.44%
KR
$263.09 18.09%
BE